Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Source: 
Xconomy
snippet: 

Acadia Pharmaceuticals has acquired Texas biotech CerSci Therapeutics, a privately held company with a clinical-stage molecule under evaluation as a potential therapy for post-surgical and nerve pain.